# Silodosin vs Tamsulosin as MET

> **NCT05570084** · PHASE3 · UNKNOWN · sponsor: **Princess Margaret Hospital, Hong Kong** · enrollment: 80 (estimated)

## Conditions studied

- Stone, Urinary

## Interventions

- **DRUG:** Silodosin
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT05570084
- **Lead sponsor:** Princess Margaret Hospital, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-31
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570084, "Silodosin vs Tamsulosin as MET". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05570084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*